News | February 18, 2022
AptarGroup reported 2021 sales at US $3.23 billion
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
New subsidiaries to be established in Malaysia, Taiwan, Singapore, and Hong Kong
The KRIVIDA Novus RT-PCR kit can detect the Omicron variant, its sub-lineages, and the Delta variant in 45 minutes
Bebtelovimab neutralizes Omicron as demonstrated by pseudo virus and authentic virus data
Immune responses were about two-to-three-fold higher in adolescents than in adults against all variants studied. Vaccine was well-tolerated with no safety signals identified
It is being developed by Pune-based Gennova Biopharmaceuticals
Glenmark received manufacturing and marketing approval from DCGI for Nitric Oxide Nasal Spray (NONS) as part of accelerated approval process
Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe
Rapid testing produces air sample results in 30 minutes
This is the ninth Covid-19 vaccine approved in India
Subscribe To Our Newsletter & Stay Updated
